Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
EV/EBIT
0.00 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Onyx Pharmaceuticals, Inc.'s enterprise value is \$0.0 Mil. Onyx Pharmaceuticals, Inc.'s earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2013 was \$-186.6 Mil. Therefore, Onyx Pharmaceuticals, Inc.'s EV/EBIT ratio for today is 0.00.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Onyx Pharmaceuticals, Inc.'s enterprise value for the quarter that ended in Jun. 2013 was \$5,773.3 Mil. Onyx Pharmaceuticals, Inc.'s earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2013 was \$-186.6 Mil. Onyx Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2013 was -3.23%.

Definition

Onyx Pharmaceuticals, Inc.'s EV/EBIT for today is calculated as:

 EV/EBIT = Enterprise Value (Today) / Earnings Before Interest and Taxes (EBIT) (TTM) = 0.000 / -186.569 = 0.00

Onyx Pharmaceuticals, Inc.'s current Enterprise Value is \$0.0 Mil.
Onyx Pharmaceuticals, Inc.'s Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2013 was -72.352 (Sep. 2012 ) + -38.211 (Dec. 2012 ) + -28.473 (Mar. 2013 ) + -47.533 (Jun. 2013 ) = \$-186.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Onyx Pharmaceuticals, Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2013 is calculated as:

 Earnings Yield (Joel Greenblatt) (Q: Jun. 2013 ) = EBIT (TTM) / Enterprise Value (Q: Jun. 2013 ) = -186.569 / 5773.3132 = -3.23 %

Onyx Pharmaceuticals, Inc.'s Enterprise Value for the quarter that ended in Jun. 2013 was \$5,773.3 Mil.
Onyx Pharmaceuticals, Inc.'s Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2013 was -72.352 (Sep. 2012 ) + -38.211 (Dec. 2012 ) + -28.473 (Mar. 2013 ) + -47.533 (Jun. 2013 ) = \$-186.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 ev2ebit -15.91 -18.73 -7.31 -1.86 -48.59 -145.05 70.57 -28.12 24.61 -17.92

Onyx Pharmaceuticals, Inc. Quarterly Data

 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 ev2ebit 0.00 0.00 0.00 24.61 22.12 117.44 0.00 0.00 0.00 0.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)